Johnson and Johnson’s one-portion antibody surrounds U.S. endorsement
(Reuters) - Johnson and Johnson (NYSE:JNJ's) one-portion COVID-19 antibody seemed protected and viable in preliminaries, the U.S. Food and Drug Administration said Wednesday, preparing for...